Extravascular ICD With a Lead Under the Sternum | EPLD
Cardioversion/Defibrillation – The World of Implantable Devices
PDF) The Extravascular Implantable Cardioverter‐Defibrillator: The Pivotal Study Plan
Initial Experience With Intercostal Insertion of an Extravascular ICD Lead Compatible With Existing Pulse Generators | Circulation: Arrhythmia and Electrophysiology
Medtronic's EV ICD System meets safety endpoints in clinical study
HRS 2023 Insights: Chronic Safety and Performance of the Extravascular ICD - Results from the Global EV ICD Pivotal Study | VuMedi
Medtronic's new extravascular ICD gains key approval
Design and Preliminary Results of Sensing and Detection for an Extravascular Implantable Cardioverter-Defibrillator - ScienceDirect
ESC 2022: Favourable results for Medtronic's EV ICD system in pivotal study
ESC 365 - Chronic safety and performance of the extravascular ICD: results from the global EV ICD Pivotal study
Extravascular ICD Pivotal Study - Clinical Trial Review - YouTube
Medtronic's breakthrough Aurora EV-ICD System receives FDA approval for life-saving cardiac treatment | HealthCare Middle East & Africa Magazine
Medtronic Initiates Worldwide Pivotal Study of Extravascular Implantable Cardioverter Defibrillator | DAIC
The extravascular implantable cardioverter‐defibrillator: The pivotal study plan - Crozier - 2021 - Journal of Cardiovascular Electrophysiology - Wiley Online Library
PDF) The Extravascular Implantable Cardioverter‐Defibrillator: The Pivotal Study Plan
Medtronic Extravascular ICD meets global pivotal clinical trial's safety and effectiveness endpoints | DAIC
Study confirms Medtronic's EV ICD's safety and effectiveness
Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias - Heart Rhythm O2
ESC 365 - Primary Outcome Results from the Global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Study .
Medtronic Cardiac on X: "See the EV ICD Pivotal Study results presented at #APHRS2023 show: https://t.co/IiBzM8qqVO #EPeeps https://t.co/Lq5LROaXOb" / X
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
The clinical and economic impact of extended battery longevity of a substernal extravascular implantable cardioverter defibrillator - Knight - Journal of Cardiovascular Electrophysiology - Wiley Online Library
Medtronic's (MDT) EV ICD Pivotal Study Shows Favorable Outcome
